Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Rifaximin (with fiber supplement)
Treatment for Diverticulitis
Typical Dosage: 400mg BID or TID (cyclical)
Effectiveness
40%
Safety Score
70%
Clinical Trials
30
Participants
5K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
400mg BID or TID (cyclical)
Time to Effect
Weeks to months
Treatment Duration
Intermittent cycles (e.g., 7-10 days/month) or continuous
Evidence Quality
MODERATENumber Needed to Treat (NNT)
25(Treat 25 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
50(Treat 50 patients to see 1 additional serious adverse event)
Confidence Score
60%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$8,000
Monitoring:$200
Side Effect Mgmt:$50
Total Annual:$8,250
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
POORQALYs Gained
0.02
Outcome-Based Costs
Cost per Responder
$27,500
Comparison vs High-Fiber Diet
Cost Difference
+$8,200/year
More expensive
QALY Difference
-0.18 QALYs
Worse outcomes
Dominance
No dominance
Prescription Access Economics
Annual Societal Loss per Patient
$6,450
Cost of prescription-only barriers (visits, time, admin, price premium)
Physician Visit Cost
$300/year
Time Cost
$100/year
Travel + wait time
Insurance Admin Cost
$50/year
Prior auth, claims
Rx Price
$8,000/year
Potential OTC Price
$2,000/year
Estimated if OTC available
Early Treatment Benefit
+0.00 QALYs
From faster OTC access
Risk Assessment
Misuse Risk
MODERATEMissed Diagnosis Risk
LOWRifaximin (with fiber supplement) Outcomes
for Diverticulitis
Efficacy Outcomes
Overall Effectiveness
+40%
Response Rate
+30%
Common Side Effects
Nausea
+7%
Abdominal pain
+5%
Peripheral edema
+6%
Dizziness
+3%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov